It is recognized that neuroinflammation can play a dual role in AD: can be protective by increasing Aβ and tau degradation and clearance but it can also contribute to their overproduction and induce neurodegeneration and synaptic loss (Novoa et al., 2022). The gene discussed is MAPT; the disease is Alzheimer disease.